850429-72-0 Usage
Uses
Used in Organic Synthesis:
N,N-DIMETHYL 3-BROMO-4-METHYLBENZENESULFONAMIDE is used as a reagent in organic synthesis for its ability to contribute to the formation of complex organic molecules, serving as a key component in the synthesis of various compounds.
Used in Pharmaceutical Research:
In pharmaceutical research, N,N-DIMETHYL 3-BROMO-4-METHYLBENZENESULFONAMIDE is utilized as a building block to create new drug candidates, leveraging its chemical properties to develop molecules with potential therapeutic applications.
Used in Pharmaceutical Formulations:
Due to its antimicrobial and antibacterial properties, N,N-DIMETHYL 3-BROMO-4-METHYLBENZENESULFONAMIDE is used as an active ingredient in pharmaceutical formulations, potentially offering treatments for bacterial infections.
Used in the Production of Pharmaceuticals:
N,N-DIMETHYL 3-BROMO-4-METHYLBENZENESULFONAMIDE is a valuable intermediate in the production of certain pharmaceuticals, playing a crucial role in the synthesis processes that yield final drug products.
Check Digit Verification of cas no
The CAS Registry Mumber 850429-72-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,0,4,2 and 9 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 850429-72:
(8*8)+(7*5)+(6*0)+(5*4)+(4*2)+(3*9)+(2*7)+(1*2)=170
170 % 10 = 0
So 850429-72-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H12BrNO2S/c1-7-4-5-8(6-9(7)10)14(12,13)11(2)3/h4-6H,1-3H3
850429-72-0Relevant academic research and scientific papers
2, 4, 6-TRI-SUBSTITUTED PYRIMIDINE COMPOUND AS ATR KINASE INHIBITOR
-
Paragraph 0160, (2022/03/22)
Compounds of general formula (A) can be used for treating ATR kinase-mediated diseases, for example, hyperplastic diseases such as cancers. Also provided are a pharmaceutical composition of the compounds of general formula (A), a use of the pharmaceutical composition for treating the ATR kinase-mediated diseases and a preparation method for the pharmaceutical composition.
